Timing note: IBM’s second-quarter earnings call is scheduled for today, Wednesday, July 22, 2026, at 5:00 p.m. ET, not tomorrow. The company already released preliminary results on July 14, so tonight’s event will be primarily about full-year guidance, the durability of software demand, and whether the quarter’s shortfall was temporary or structural.
This is no longer a conventional earnings report. IBM has already disclosed most of the headline numbers—and they were meaningfully below expectations. The stock has fallen approximately 27% since July 13, including a 25% decline immediately following the warning.
The central investment question is:
Did IBM suffer a short-lived disruption in deal timing and customer budgets, or is AI infrastructure spending structurally crowding out demand for IBM’s software and mainframe ecosystem?
Management’s guidance will matter far more than small changes to the preliminary figures. A credible explanation, evidence that delayed deals remain recoverable, and preservation of free-cash-flow expectations could stabilize the shares. A substantial guidance cut—or vague answers on software demand—would suggest that the July 14 selloff was not merely an overreaction.
| Q2 preliminary result | Performance |
|---|---|
| Revenue | $17.2 billion, up 1% |
| Software revenue | Up 5% |
| Consulting revenue | Flat; up 1% at constant currency |
| Infrastructure revenue | Down 7% |
| Operating gross margin | 59.4%, down 70 bps |
| Operating pretax margin | 19.2%, up 30 bps |
| Adjusted EPS | $2.93, up 5% |
| GAAP EPS | $2.27, down 2% |
| First-half free cash flow | $4.76 billion |
Before the warning, consensus was approximately $17.86 billion of revenue and $3.01–$3.02 of adjusted EPS. The preliminary figures therefore missed revenue expectations by roughly 4% and EPS by approximately 3%.
IBM attributed most of the shortfall to:
Management emphasized that Red Hat accelerated to 11% growth, recent acquisitions performed well, and Distributed Infrastructure grew 37%. But these positives did not offset weakness in the more profitable mainframe-related software stack.
IBM entered the quarter targeting:
Several of those assumptions now appear difficult to retain unchanged.
Software grew only 5% in Q2, despite contributions from Confluent and HashiCorp. Infrastructure declined 7%, versus the prior expectation for only a low-single-digit full-year decline. Consulting also failed to show the anticipated acceleration.
The call needs to provide a complete, quantified reset rather than simply characterize Q2 as disappointing. Investors should focus on:
A modest revenue reduction accompanied by stable margin and cash-flow guidance would be considerably better than a broad reset across all metrics.
Software is the foundation of IBM’s investment case. It represents roughly 45% of revenue but a much larger share of profit, and it was expected to produce more than 10% growth this year.
The Q2 composition was mixed:
The key issue is whether customers merely delayed transactions into the second half or have made more durable changes to technology budgets. Management’s explanation—that customers unexpectedly redirected spending toward memory, servers and storage—is plausible, but it raises another concern: those infrastructure requirements may remain expensive for several quarters rather than disappear after June.
Investors should listen for:
Red Hat’s 11% growth is an important support, but it will not fully answer concerns if the rest of the software portfolio remains weak.
The most confusing aspect of the warning is that IBM says z17 remains an exceptionally strong program—at nearly 130% of the comparable prior cycle—while also reporting a sharp quarterly Z and Transaction Processing shortfall.
That tension needs to be resolved.
IBM had warned that Infrastructure would decline after wrapping the unusually strong z17 launch. But the company expected a manageable product-cycle decline, not the magnitude experienced in Q2. Management now says numerous large transactions did not close on time.
The critical distinction is between:
IBM also exited Q2 with approximately $500 million of Distributed Infrastructure backlog, following 37% growth in Power and Storage. Investors should determine whether this represents incremental demand or merely spending redirected away from higher-margin IBM Z and software offerings.
A dollar-based bridge of delayed deals, cancellations and expected second-half closings would be much more useful than additional program-to-program percentages.
There was one meaningful positive in the preliminary results: operating pretax margin expanded 30 basis points, even though operating gross margin declined 70 basis points. Productivity initiatives appear to have offset weaker mix and acquisition-related dilution below the gross-profit line.
IBM generated $4.76 billion of free cash flow during the first half. Since Q1 free cash flow was $2.22 billion, Q2 contributed approximately $2.54 billion.
To achieve the previous $15.7 billion full-year target, IBM would need roughly $10.94 billion in the second half, or nearly 70% of its annual cash flow. IBM’s cash generation is seasonally weighted toward the end of the year, so this is not inherently impossible. But weaker software transactions and delayed customer payments increase the execution risk.
Points to watch include:
Preserving the free-cash-flow target would provide an important valuation anchor. A material reduction would weaken both the dividend-support argument and the post-selloff value case.
IBM has positioned itself as an enterprise AI beneficiary through Red Hat, watsonx, automation, Consulting, mainframe inferencing and governed data infrastructure. Q2 exposed the other side of that thesis: AI infrastructure costs can absorb technology budgets that otherwise would have been available for software and services.
Management needs to distinguish between two narratives:
IBM’s preferred narrative
The market’s concern
Specific evidence—closed transactions, pipeline conversion, renewals and second-half customer commitments—will matter more than broad commentary about the long-term AI opportunity.
IBM completed the approximately $11.6 billion acquisition of Confluent in March. At the end of Q1, IBM reported:
Confluent appears to be performing well operationally, but its acquisition increased interest expense, stock-based compensation and integration risk. IBM previously expected around $600 million of 2026 dilution, while targeting approximately $500 million of operational run-rate synergies by the end of 2027.
Questions for management include:
Following the warning, balance-sheet discipline and integration execution should take priority over another large transaction.
IBM closed at $210.54 on July 21, down roughly 27.5% from its July 13 close of $290.23. Using the Q1 diluted share count, the current equity value is approximately $200 billion.
If IBM maintains its previous $15.7 billion free-cash-flow forecast, the shares trade at roughly:
Those figures look inexpensive relative to IBM’s recent valuation—but only if free cash flow is durable. The stock is not necessarily cheap if Q2 represents the beginning of a multiquarter software slowdown. Consequently, the most important valuation input tonight is not final Q2 EPS; it is the revised cash-flow outlook.
This would support the argument that the 25% one-day selloff priced in too prolonged a downturn.
This could stabilize the stock, but a sustained recovery would require evidence of better execution in Q3.
That combination would validate concerns that IBM’s problem extends beyond one quarter.
The headline Q2 miss is already known and largely reflected in the stock. Tonight’s call is a test of credibility and visibility.
IBM needs to demonstrate that:
At roughly 13 times the previous free-cash-flow forecast, IBM could offer meaningful upside if the cash-flow outlook remains intact and Q2 proves anomalous. But without quantified evidence of a second-half recovery, the lower valuation should be viewed as compensation for materially higher execution and demand risk—not automatically as a buying opportunity.
Sources: IBM preliminary Q2 results and investor letter dated July 14, 2026; IBM Q1 2026 Form 10-Q and earnings call; IBM 2025 Q4 earnings call; recent market-news and stock-price data through July 21, 2026.